African Burkitt's lymphoma: a plant, Euphorbia tirucalli, reduces Epstein-Barr virus-specific cellular immunity

Anticancer Res. 1994 May-Jun;14(3A):933-6.

Abstract

Endemicity of Burkitt's lymphoma (BL) coincides with profusion of a plant Euphorbia tirucalli in tropical Africa. E. tirucalli contains 4-deoxyphorbol ester that enhances Epstein-Barr virus (EBV) infection of B lymphocytes. In this study, we found that 4-deoxyphorbol ester reduced EBV-specific cytotoxic T-cell function. Furthermore, the B lymphocytes dually exposed to EBV and 4-deoxyphorbol ester were resistant to EBV-specific T cell cytotoxicity, through down-regulation of latent membrane protein 1 (LMP1), the major target to EBV-specific cytotoxic T-cells. These immunologic findings strengthen the notion that E. tirucalli may be an important environmental risk factor for the genesis of African BL.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Africa
  • Burkitt Lymphoma / etiology*
  • Burkitt Lymphoma / immunology
  • Cytotoxicity, Immunologic / drug effects
  • Genes, myc
  • Herpesvirus 4, Human / immunology*
  • Humans
  • Immunity, Cellular / drug effects
  • Immunosuppressive Agents / toxicity*
  • Lymphocytes / drug effects*
  • Lymphocytes / immunology
  • Oncogene Proteins, Viral / analysis
  • Phorbol Esters / toxicity*
  • Plants, Toxic*
  • Viral Matrix Proteins / analysis

Substances

  • EBV-associated membrane antigen, Epstein-Barr virus
  • Immunosuppressive Agents
  • Oncogene Proteins, Viral
  • Phorbol Esters
  • Viral Matrix Proteins